MedTrace Logo

Postbiotic as Adjunct Treatment for Vaginal Candidiasis

NCT06474247 · Status: RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2024-07-05

No results posted yet for this study

Summary

This project aims to study the efficacy of intravaginal administration of postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks compared to placebo.

Conditions

  • Vaginal Candidiasis

Interventions

DEVICE

Postbiotic

Postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks

DEVICE

Placebo

Placebo at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks

Sponsors & Collaborators

  • AIMST University

    collaborator UNKNOWN

  • Sumita Hospital

    collaborator UNKNOWN

  • Min-Tze LIONG

    lead OTHER

Principal Investigators

  • Sumita Bhatia, MD · Sumita Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
81 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-02
Primary Completion
2025-06-02
Completion
2025-06-02

Countries

  • India
  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06474247 on ClinicalTrials.gov